727 related articles for article (PubMed ID: 20346634)
1. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
2. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
Ooi N; Miller K; Hobbs J; Rhys-Williams W; Love W; Chopra I
J Antimicrob Chemother; 2009 Oct; 64(4):735-40. PubMed ID: 19689976
[TBL] [Abstract][Full Text] [Related]
3. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP
Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
Hadjivassileva T; Thurston DE; Taylor PW
J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
14. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
Stefani S; Debbia EA; Schito GC; Russo G
Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
Vooturi SK; Cheung CM; Rybak MJ; Firestine SM
J Med Chem; 2009 Aug; 52(16):5020-31. PubMed ID: 19653650
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial effect of water extract of sumac (Rhus coriaria L.) on the growth of some food borne bacteria including pathogens.
Nasar-Abbas SM; Halkman AK
Int J Food Microbiol; 2004 Dec; 97(1):63-9. PubMed ID: 15527919
[TBL] [Abstract][Full Text] [Related]
18. New insights into the antibacterial mechanism of action of squalamine.
Alhanout K; Malesinki S; Vidal N; Peyrot V; Rolain JM; Brunel JM
J Antimicrob Chemother; 2010 Aug; 65(8):1688-93. PubMed ID: 20551217
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
Gales AC; Sader HS; Jones RN
Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
